Monsanto Co. (MON) Given Buy Rating at Argus
Monsanto Co. (NYSE:MON)‘s stock had its “buy” rating reissued by research analysts at Argus in a report issued on Sunday. They currently have a $128.00 price objective on the stock. Argus’ price objective points to a potential upside of 23.84% from the stock’s current price.
A number of other research analysts have also recently issued reports on the company. BMO Capital Markets reiterated an “outperform” rating and issued a $128.00 target price on shares of Monsanto in a research report on Saturday. JPMorgan Chase & Co. set a $128.00 target price on Monsanto and gave the company a “buy” rating in a research report on Thursday. Zacks Investment Research cut Monsanto from a “hold” rating to a “strong sell” rating in a research report on Friday. Deutsche Bank AG reiterated a “buy” rating on shares of Monsanto in a research report on Thursday. Finally, Barclays PLC reiterated a “hold” rating and issued a $110.00 target price on shares of Monsanto in a research report on Thursday. Three analysts have rated the stock with a sell rating, eight have assigned a hold rating, fifteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average price target of $114.67.
Shares of Monsanto (NYSE:MON) opened at 103.36 on Friday. Monsanto has a 12 month low of $83.73 and a 12 month high of $114.26. The firm has a market capitalization of $45.23 billion, a P/E ratio of 45.49 and a beta of 1.19. The company has a 50 day moving average of $104.86 and a 200-day moving average of $101.43.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/10/09/monsanto-co-mon-given-buy-rating-at-argus.html
Monsanto (NYSE:MON) last released its earnings results on Wednesday, October 5th. The company reported $0.07 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.02) by $0.09. Monsanto had a return on equity of 46.07% and a net margin of 9.89%. The firm had revenue of $2.56 billion for the quarter, compared to analysts’ expectations of $2.38 billion. During the same quarter in the previous year, the business posted ($0.19) earnings per share. The business’s revenue for the quarter was up 8.8% on a year-over-year basis. Analysts predict that Monsanto will post $4.89 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 28th. Shareholders of record on Friday, October 7th will be paid a $0.54 dividend. The ex-dividend date is Wednesday, October 5th. This represents a $2.16 dividend on an annualized basis and a yield of 2.09%. Monsanto’s dividend payout ratio (DPR) is presently 71.05%.
In other Monsanto news, CEO Michael K. Stern sold 12,797 shares of the company’s stock in a transaction on Wednesday, July 13th. The stock was sold at an average price of $101.77, for a total value of $1,302,350.69. Following the completion of the transaction, the chief executive officer now owns 21,583 shares in the company, valued at approximately $2,196,501.91. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Brett D. Begemann sold 27,980 shares of the company’s stock in a transaction on Thursday, July 14th. The shares were sold at an average price of $103.62, for a total value of $2,899,287.60. Following the completion of the transaction, the chief operating officer now owns 102,480 shares of the company’s stock, valued at approximately $10,618,977.60. The disclosure for this sale can be found here. 0.88% of the stock is owned by company insiders.
A number of hedge funds and other institutional investors have recently made changes to their positions in MON. FMR LLC increased its position in shares of Monsanto by 41.3% in the second quarter. FMR LLC now owns 16,593,757 shares of the company’s stock worth $1,715,960,000 after buying an additional 4,851,499 shares during the period. Third Point LLC acquired a new position in shares of Monsanto during the second quarter worth about $206,820,000. Carmignac Gestion acquired a new position in shares of Monsanto during the second quarter worth about $197,555,000. TIAA CREF Investment Management LLC increased its position in shares of Monsanto by 50.4% in the second quarter. TIAA CREF Investment Management LLC now owns 4,658,464 shares of the company’s stock worth $481,732,000 after buying an additional 1,560,646 shares during the period. Finally, Adage Capital Partners GP L.L.C. increased its position in shares of Monsanto by 205.6% in the second quarter. Adage Capital Partners GP L.L.C. now owns 1,705,121 shares of the company’s stock worth $176,327,000 after buying an additional 1,147,200 shares during the period. Hedge funds and other institutional investors own 79.02% of the company’s stock.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related companies with MarketBeat.com's FREE daily email newsletter.